Bachem
EMEA
Bubendorf
,
Switzerland
Multinational
FOUNDED
1971
HEADCOUNT
1001-5000
FUNDING
Public
Keywords:
CDMO, therapeutics, DNA_synthesis
BUSINESS
CDMO specializing in development and GMP manufacture of peptides and oligonucleotides as active pharmaceutical ingredients. Provides custom synthesis through to commercial-scale production for pharma and biotech clients worldwide.
BIOTECH INVOLVEMENT
Adjacent; specialty CDMO whose core expertise is solid-phase peptide synthesis (SPPS) and chemical oligonucleotide synthesis at GMP scale. Recombinant routes are a smaller capability used selectively; production technology is predominantly chemical synthesis of biologically active molecules.
TECHNOLOGY PLATFORM
peptide synthesis; oligonucleotide manufacturing; GMP processes
PRIMARY PRODUCTS
peptide APIs; oligonucleotide APIs; custom peptides